Gastrointestinal hypermotility
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB13520 | Metergoline | An ergot-derivative that acts as an antagonist at certain 5-HT receptor subtypes and as an agonist at dopamine receptors. It is often used in situations where inhibition of prolactin is desirable. |
| DB13844 | Pipenzolate | An antimuscarinic agent indicated in the treatment of gastrointestinal motility disorders and arrhythmia. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB13520 | Metergoline | Sodium channel protein type 2 subunit alpha | target |
| Drug | Drug Name | Phase | Status | Count |
|---|